Detailed information for compound 1950347

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 459.474 | Formula: C28H18FN5O
  • H donors: 0 H acceptors: 4 LogP: 5.19 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc2ncc3c(c2cc1c1cnc2c(c1)cccc2)c(nn3C)c1ccc(cc1F)C#N
  • InChi: 1S/C28H18FN5O/c1-34-25-15-32-24-12-26(35-2)20(18-10-17-5-3-4-6-23(17)31-14-18)11-21(24)27(25)28(33-34)19-8-7-16(13-30)9-22(19)29/h3-12,14-15H,1-2H3
  • InChiKey: CREGPMVOCLDQMA-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens protein kinase, DNA-activated, catalytic polypeptide Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis DNA dependent protein kinase catalytic subunit Get druggable targets OG5_132688 All targets in OG5_132688
Echinococcus granulosus DNA dependent protein kinase catalytic subunit Get druggable targets OG5_132688 All targets in OG5_132688
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.0022 0.0271 1
Trypanosoma brucei phosphatidylinositol 3-kinase, putative 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Schistosoma mansoni phosphatidylinositol 3-and 4-kinase 0.0022 0.0271 0.5
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.0022 0.0271 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Loa Loa (eye worm) phosphatidylinositol 3 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Loa Loa (eye worm) phosphatidylinositol 3 0.0022 0.0271 1
Leishmania major hypothetical protein, conserved 0.0114 0.334 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.0022 0.0271 0.5
Echinococcus multilocularis DNA dependent protein kinase catalytic subunit 0.0313 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trypanosoma cruzi hypothetical protein, conserved 0.011 0.32 1
Giardia lamblia GTOR 0.0022 0.0271 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Toxoplasma gondii target of rapamycin (TOR), putative 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0022 0.0271 0.5
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0022 0.0271 0.5
Trypanosoma brucei target of rapamycin kinase 3, putative 0.0022 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0022 0.0271 1
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.0022 0.0271 0.5
Trypanosoma brucei phosphatidylinositol 3-related kinase, putative 0.0022 0.0271 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) < 100 nM BindingDB_Patents: Biochemical Assay. The kinase assay was carried out in streptavidin-coated 348-well microtitre FlashPlates®. To this end, 1.5 µg of the DNA-PK/protein complex and 100 ng of biotinylated substrate, such as, for example, PESQEAFADLWKK biotin-NH2 (biotin-DNA-PK peptide), in a total volume of 36.5 µl (34.25 mM HEPES/KOH, 7.85 mM Tris-HCl, 68.5 mM KCl, 5 µM ATP, 6.85 mM MgCl2, 0.5 mM EDTA, 0.14 mM EGTA, 0.69 mM DTT, pH 7.4), were incubated at room temperature for 90 min with 500 ng of DNA from calf thymus, 0.1 µCi of 33P-ATP and 1.8% of DMSO per well with or without the test compound. The reaction was stopped using 50 µl/well of 200 mM EDTA. After incubation for a further 30 min at room temperature, the liquid was removed. Each well was washed three times with 100 µl of 0.9% sodium chloride solution. A non-specific reaction (blank value) was determined using 10 µM of a proprietary kinase inhibitor. ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.